Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Teva CEO Kåre Schultz brought home $14.7M last year, soaring past some of Europe's top-paid pharma execs
4 years ago
People
Sanofi preps API spinoff for Paris exchange listing, shareholders reap dividend
4 years ago
Manufacturing
Pfizer CEO to haul in almost $50M in compensation in 2021 and 2022
4 years ago
People
Novartis suffers a loss in its fight to block Regenxbio's Zolgensma patent extension
4 years ago
Cell/Gene Tx
Law
Noted: AstraZeneca re-ups lung cancer campaign to send encouraging letters to patients and caregivers
4 years ago
Marketing
On the heels of FDA rejection, tiny Zosano cuts about a third of its workforce as latest victim of the budget axe
4 years ago
People
Hot on Roche’s heels, Merck spells out mixed Keytruda data in adjuvant NSCLC
4 years ago
R&D
Pharma watchdog calls out AstraZeneca, GlaxoSmithKline for breaches on online conduct
4 years ago
Real Chemistry recaps banner 2021, sets ‘change agent’ goals moving beyond Covid-19 pandemic
4 years ago
Marketing
Merck KGaA to pay over $3M to patients after drug formulation change-up triggered complaints
4 years ago
Law
Embroiled in a years-long legal saga, CareDx pulls a win over Natera in false advertising case
4 years ago
Law
Two US companies ink deals to expand biosimilar offerings
4 years ago
Manufacturing
GSK falls in line with Big Pharma's reaction to Ukraine invasion, cutting off new clinical trials, donating profits and more
4 years ago
Biogen loses another bid to revive Tecfidera patent as generic keeps eating into blockbuster sales
4 years ago
Law
AstraZeneca shells out $775M to settle Ultomiris patent suit with Roche
4 years ago
Law
Covid-19 vaccine marketing roundup: New data bolster case for J&J's single-dose vaccine — report; Germany inks deals with vaccine makers in preparation for future outbreaks
4 years ago
Coronavirus
J&J's Alex Gorsky bagged $26M in pay and perks for 2021, landing near the top of the Big Pharma CEO ladder
4 years ago
People
SEC issues preliminary injunction against Colorado biotech accused of $10M fraud
4 years ago
Manufacturing
Beverly Hills plastic surgeon leads pharma manufacturing build in his native Ghana
4 years ago
Manufacturing
Publicis brings back its HealthFront dealmaking marketplace for pharma and healthcare advertisers
4 years ago
Marketing
Pharma industry reputation continues to slide, according to new Harris Poll. But how low can it go?
4 years ago
Marketing
Negotiations or price controls? Senate Finance Committee splits along party lines over drug prices
4 years ago
Roche uncorks new long-term data as SMA rivalry heats up
4 years ago
Marketing
Biogen finally publishes PhIII results for Aduhelm as critics chastise low-ranking journal, ‘gentle and unrevealing’ peer review
4 years ago
First page
Previous page
215
216
217
218
219
220
221
Next page
Last page